Scott Leffler named CFO at Myriad
Plus: Brian MacDonald retires as chief innovation officer at Disc, and updates from BioAgeis and Sofinnova Partners
Scott Leffler will become CFO of Myriad Genetics Inc. (NASDAQ:MYGN) on Jan. 29 following the retirement of CFO Bryan Riggsbee, who will continue as strategic adviser until March 31. Leffler was CFO at Clover Health and Sotera Health Co. (NASDAQ:SHC).
Brian MacDonald is retiring as chief innovation officer of Disc Medicine Inc. (NASDAQ:IRON) and will become chair of its scientific advisory board. Disc is developing therapies for serious hematological diseases...
BCIQ Company Profiles